SILK
$47.95
Silk Road Medical
$.61
1.29%
SILK
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.37)
Revenue:  $24.79 Mil
Tuesday
Aug 3
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when SILK reports earnings?
Beat
Meet
Miss

Where is SILK's stock price going from here?
Up
Flat
Down
Stock chart of SILK
Analysts
Summary of analysts' recommendations for SILK
Score
Grade
Pivots
Resistance
$51.28
$50.22
$49.09

$48.03

Support
$46.90
$45.84
$44.71
Tweet
Growth
Description
Silk Road Medical Inc. is a medical device company. It is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization. TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Silk Road Medical Inc. is based in Sunnyvale, California.